These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25644017)

  • 21. Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-α fusion protein mediated by urokinase.
    Dai YC; Yang SM; Wang X; Zhou YJ; Hou G; Huang DN
    Mol Med Rep; 2015 Jun; 11(6):4333-40. PubMed ID: 25672264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS; Penichet ML; Morrison SL
    J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation.
    Zhang HY; Xu WQ; Wang YW; Omari-Siaw E; Wang Y; Zheng YY; Cao X; Tong SS; Yu JN; Xu XM
    Int J Pharm; 2016 Apr; 502(1-2):98-106. PubMed ID: 26899980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
    Boismenu R; Semeniuk D; Murgita RA
    Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGD-IL-24, a novel tumor-targeted fusion cytokine: expression, purification and functional evaluation.
    Xiao B; Li W; Yang J; Guo G; Mao XH; Zou QM
    Mol Biotechnol; 2009 Feb; 41(2):138-44. PubMed ID: 18953678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of cancer cell lines for peptide receptor-targeted drug development.
    Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT; Chen NY; Franek KJ; Chen WY
    Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodies.
    Liu R; Jiang W; Yang M; Guo H; Zhang Y; Wang J; Zhu H; Shi R; Fan D; Yang C; Zhu Z; Xie Y; Xiong D
    J Immunother; 2010 Jun; 33(5):500-9. PubMed ID: 20463597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and functional characterization of human vascular endothelial growth factor-melittin fusion protein with analysis of the antitumor activity in vitro and in vivo.
    Wang D; Hu L; Su M; Wang J; Xu T
    Int J Oncol; 2015 Sep; 47(3):1160-8. PubMed ID: 26166416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of scFv-Mel-Gal4 triple fusion protein as a targeted DNA-carrier in Escherichia Coli.
    Wang W; Luo J; Xu L; Zeng J; Cao L; Dong J; Cai S
    Cell Biochem Funct; 2013 Dec; 31(8):698-706. PubMed ID: 23508530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two characteristics of a recombinant fusion protein composed of staphylokinase and hirudin: high thrombus affinity and thrombus-targeting release ofanticoagulant activity.
    Yu A; Zhang C; Dong C; Yu H; Zhong G; Wang L; Wu C
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1955-61. PubMed ID: 19256345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.
    Wang WW; Das D; McQuarrie SA; Suresh MR
    Eur J Pharm Biopharm; 2007 Mar; 65(3):398-405. PubMed ID: 17257818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting.
    Rohrbach F; Gerstmayer B; Biburger M; Wels W
    Clin Cancer Res; 2000 Nov; 6(11):4314-22. PubMed ID: 11106249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
    Wang CH; Tang CW
    Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.
    Siemers NO; Kerr DE; Yarnold S; Stebbins MR; Vrudhula VM; Hellström I; Hellström KE; Senter PD
    Bioconjug Chem; 1997; 8(4):510-9. PubMed ID: 9258449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.